HUM
Humana Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$400.48
−1.49%Year over year
Reported trailing growth
- Revenue
- +18.3%
- EBITDA
- -16.3%
- EBIT
- -4.0%
- EPS
- -18.5%
- Free cash flow
- —
- Operating cash flow
- -95.0%
Forward estimates
Based on analyst estimates
- Revenue
- +13.6%
- EBITDA
- +18.2%
- EPS
- +15.7%
Three-year CAGR
- Revenue
- +11.7%
- EBITDA
- -15.4%
- EBIT
- -25.9%
- Net income
- -24.9%
- EPS
- -23.7%
- Free cash flow
- -52.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026